Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret model.

Satterfield BA, Borisevich V, Foster SL, Rodriguez SE, Cross RW, Fenton KA, Agans KN, Basler CF, Geisbert TW, Mire CE.

Sci Rep. 2019 Nov 13;9(1):16710. doi: 10.1038/s41598-019-53037-0.

2.

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.

Mire CE, Chan YP, Borisevich V, Cross RW, Yan L, Agans KN, Dang HV, Veesler D, Fenton KA, Geisbert TW, Broder CC.

J Infect Dis. 2019 Nov 4. pii: jiz515. doi: 10.1093/infdis/jiz515. [Epub ahead of print]

PMID:
31686101
3.

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.

Geisbert JB, Borisevich V, Prasad AN, Agans KN, Foster SL, Deer DJ, Cross RW, Mire CE, Geisbert TW, Fenton KA.

J Infect Dis. 2019 Oct 30. pii: jiz391. doi: 10.1093/infdis/jiz391. [Epub ahead of print]

PMID:
31665362
4.

A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.

Prasad AN, Agans KN, Sivasubramani SK, Geisbert JB, Borisevich V, Mire CE, Lawrence WS, Fenton KA, Geisbert TW.

J Infect Dis. 2019 Oct 30. pii: jiz469. doi: 10.1093/infdis/jiz469. [Epub ahead of print]

PMID:
31665351
5.

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.

Woolsey C, Menicucci AR, Cross RW, Luthra P, Agans KN, Borisevich V, Geisbert JB, Mire CE, Fenton KA, Jankeel A, Anand S, Ebihara H, Geisbert TW, Messaoudi I, Basler CF.

Cell Rep. 2019 Sep 17;28(12):3032-3046.e6. doi: 10.1016/j.celrep.2019.08.047.

6.

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE.

iScience. 2019 Sep 27;19:1279-1290. doi: 10.1016/j.isci.2019.07.003. Epub 2019 Aug 8.

7.

A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.

Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, Wirchnianski AS, Goodwin E, Tierney K, Shestowsky WS, Bohorov O, Bohorova N, Velasco J, Ailor E, Kim D, Pauly MH, Whaley KJ, Alter G, Walker LM, Chandran K, Zeitlin L, Qiu X, Geisbert TW, Dye JM.

Cell Host Microbe. 2019 Jan 9;25(1):49-58.e5. doi: 10.1016/j.chom.2018.12.005.

PMID:
30629918
8.

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans.

Cross RW, Speranza E, Borisevich V, Widen SG, Wood TG, Shim RS, Adams RD, Gerhardt DM, Bennett RS, Honko AN, Johnson JC, Hensley LE, Geisbert TW, Connor JH.

J Infect Dis. 2018 Nov 22;218(suppl_5):S486-S495. doi: 10.1093/infdis/jiy455.

9.

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo).

Cross RW, Mire CE, Agans KN, Borisevich V, Fenton KA, Geisbert TW.

J Infect Dis. 2018 Nov 22;218(suppl_5):S448-S452. doi: 10.1093/infdis/jiy268.

10.

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.

Woolsey C, Geisbert JB, Matassov D, Agans KN, Borisevich V, Cross RW, Deer DJ, Fenton KA, Eldridge JH, Mire CE, Geisbert TW.

J Infect Dis. 2018 Nov 22;218(suppl_5):S582-S587. doi: 10.1093/infdis/jiy293.

11.

Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.

Leon AJ, Borisevich V, Boroumand N, Seymour R, Nusbaum R, Escaffre O, Xu L, Kelvin DJ, Rockx B.

PLoS Negl Trop Dis. 2018 Mar 14;12(3):e0006343. doi: 10.1371/journal.pntd.0006343. eCollection 2018 Mar.

12.

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.

Mire CE, Cross RW, Geisbert JB, Borisevich V, Agans KN, Deer DJ, Heinrich ML, Rowland MM, Goba A, Momoh M, Boisen ML, Grant DS, Fullah M, Khan SH, Fenton KA, Robinson JE, Branco LM, Garry RF, Geisbert TW.

Nat Med. 2017 Oct;23(10):1146-1149. doi: 10.1038/nm.4396. Epub 2017 Sep 4.

13.

Hendra and Nipah Virus Infection in Cultured Human Olfactory Epithelial Cells.

Borisevich V, Ozdener MH, Malik B, Rockx B.

mSphere. 2017 Jun 28;2(3). pii: e00252-17. doi: 10.1128/mSphere.00252-17. eCollection 2017 May-Jun.

14.

Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.

Mire CE, Geisbert JB, Borisevich V, Fenton KA, Agans KN, Flyak AI, Deer DJ, Steinkellner H, Bohorov O, Bohorova N, Goodman C, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Crowe JE Jr, Zeitlin L, Geisbert TW.

Sci Transl Med. 2017 Apr 5;9(384). pii: eaai8711. doi: 10.1126/scitranslmed.aai8711.

15.

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.

Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW.

Sci Rep. 2016 Aug 3;6:30916. doi: 10.1038/srep30916.

16.

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.

Cross RW, Mire CE, Borisevich V, Geisbert JB, Fenton KA, Geisbert TW.

J Infect Dis. 2016 Aug 15;214(4):565-9. doi: 10.1093/infdis/jiw209. Epub 2016 May 24.

17.

Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Satterfield BA, Cross RW, Fenton KA, Borisevich V, Agans KN, Deer DJ, Graber J, Basler CF, Geisbert TW, Mire CE.

J Virol. 2016 Jun 24;90(14):6326-6343. doi: 10.1128/JVI.00215-16. Print 2016 Jul 15.

18.

Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface.

Escaffre O, Borisevich V, Vergara LA, Wen JW, Long D, Rockx B.

J Gen Virol. 2016 May;97(5):1077-1086. doi: 10.1099/jgv.0.000441. Epub 2016 Mar 1.

19.

The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Pécheur EI, Borisevich V, Halfmann P, Morrey JD, Smee DF, Prichard M, Mire CE, Kawaoka Y, Geisbert TW, Polyak SJ.

J Virol. 2016 Jan 6;90(6):3086-92. doi: 10.1128/JVI.02077-15.

20.

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo.

Borisevich V, Lee B, Hickey A, DeBuysscher B, Broder CC, Feldmann H, Rockx B.

J Infect Dis. 2016 Feb 1;213(3):448-55. doi: 10.1093/infdis/jiv449. Epub 2015 Sep 10.

21.

Oxidative stress in Nipah virus-infected human small airway epithelial cells.

Escaffre O, Halliday H, Borisevich V, Casola A, Rockx B.

J Gen Virol. 2015 Oct;96(10):2961-70. doi: 10.1099/jgv.0.000243. Epub 2015 Jul 14.

22.

Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species.

Hernandez H, Marceau C, Halliday H, Callison J, Borisevich V, Escaffre O, Creech J, Feldmann H, Rockx B.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S410-3. doi: 10.1093/infdis/jiv209. Epub 2015 May 21.

23.

A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.

Johnson JB, Borisevich V, Rockx B, Parks GD.

J Virol. 2015 Jan 15;89(2):989-98. doi: 10.1128/JVI.02427-14. Epub 2014 Oct 29.

24.

A human lung xenograft mouse model of Nipah virus infection.

Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B.

PLoS Pathog. 2014 Apr 3;10(4):e1004063. doi: 10.1371/journal.ppat.1004063. eCollection 2014 Apr.

25.

Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Bente D, Paessler S.

J Virol. 2013 Oct;87(19):10908-11. doi: 10.1128/JVI.01433-13. Epub 2013 Jul 31.

26.

Pathogenesis of Hendra and Nipah virus infection in humans.

Escaffre O, Borisevich V, Rockx B.

J Infect Dev Ctries. 2013 Apr 17;7(4):308-11. doi: 10.3855/jidc.3648. Review.

27.

Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation.

Peng BH, Borisevich V, Popov VL, Zacks MA, Estes DM, Campbell GA, Paessler S.

Vet Microbiol. 2013 May 3;163(3-4):223-34. doi: 10.1016/j.vetmic.2012.11.021. Epub 2013 Jan 11.

PMID:
23428380
28.

Henipavirus pathogenesis in human respiratory epithelial cells.

Escaffre O, Borisevich V, Carmical JR, Prusak D, Prescott J, Feldmann H, Rockx B.

J Virol. 2013 Mar;87(6):3284-94. doi: 10.1128/JVI.02576-12. Epub 2013 Jan 9.

29.

Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.

Jones FR, Gabitzsch ES, Xu Y, Balint JP, Borisevich V, Smith J, Smith J, Peng BH, Walker A, Salazar M, Paessler S.

Vaccine. 2011 Sep 16;29(40):7020-6. doi: 10.1016/j.vaccine.2011.07.073. Epub 2011 Aug 5.

30.

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, Borisevich V, Linde JJ, Zacks MA, Li H, Kavita U, Reiserova L, Liu X, Dumuren K, Balasubramanian B, Weaver B, Parent J, Umlauf S, Liu G, Huleatt J, Tussey L, Paessler S.

Vaccine. 2009 Sep 25;27(42):5875-84. doi: 10.1016/j.vaccine.2009.07.060. Epub 2009 Aug 3.

31.

CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.

Yun NE, Peng BH, Bertke AS, Borisevich V, Smith JK, Smith JN, Poussard AL, Salazar M, Judy BM, Zacks MA, Estes DM, Paessler S.

Vaccine. 2009 Jun 19;27(30):4064-73. doi: 10.1016/j.vaccine.2009.04.015. Epub 2009 May 3.

32.

Depleted zinc: Properties, application, production.

Borisevich VD, Pavlov AV, Okhotina IA.

Appl Radiat Isot. 2009 Jul-Aug;67(7-8):1167-72. doi: 10.1016/j.apradiso.2009.02.063. Epub 2009 Feb 25.

PMID:
19318263
33.

Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers.

Paessler S, Rijnbrand R, Stein DA, Ni H, Yun NE, Dziuba N, Borisevich V, Seregin A, Ma Y, Blouch R, Iversen PL, Zacks MA.

Virology. 2008 Jul 5;376(2):357-70. doi: 10.1016/j.virol.2008.03.032. Epub 2008 May 12.

34.

A highly sensitive and versatile virus titration assay in the 96-well microplate format.

Borisevich V, Nistler R, Hudman D, Yamshchikov G, Seregin A, Yamshchikov V.

J Virol Methods. 2008 Feb;147(2):197-205.

PMID:
18079007
35.

Genetically delivered antibody protects against West Nile virus.

Pereboev A, Borisevich V, Tsuladze G, Shakhmatov M, Hudman D, Kazachinskaia E, Razumov I, Svyatchenko V, Loktev V, Yamshchikov V.

Antiviral Res. 2008 Jan;77(1):6-13. Epub 2007 Sep 14.

36.

Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.

Seregin A, Nistler R, Borisevich V, Yamshchikov G, Chaporgina E, Kwok CW, Yamshchikov V.

Virology. 2006 Dec 5-20;356(1-2):115-25. Epub 2006 Aug 28.

37.

Biological properties of chimeric West Nile viruses.

Borisevich V, Seregin A, Nistler R, Mutabazi D, Yamshchikov V.

Virology. 2006 Jun 5;349(2):371-81. Epub 2006 Mar 20.

38.

The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.

Yamshchikov G, Borisevich V, Kwok CW, Nistler R, Kohlmeier J, Seregin A, Chaporgina E, Benedict S, Yamshchikov V.

Vaccine. 2005 Sep 15;23(39):4785-92.

PMID:
15939510
39.

An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.

Yamshchikov G, Borisevich V, Seregin A, Chaporgina E, Mishina M, Mishin V, Kwok CW, Yamshchikov V.

Virology. 2004 Dec 5;330(1):304-12.

40.

[Molecular typing of the tick-borne encephalitis virus isolated from patients with different-infection severities in the south of Russia's Far East].

Leonova GN, Belikov SI, Kulakova NV, Pavlenko EV, Borisevich VG.

Mol Gen Mikrobiol Virusol. 2004;(2):32-7. Russian.

PMID:
15164719
41.

[Changes in the immune status parameters and their correction in various forms of tick-borne encephalitis].

Krylova NV, Iakusheva SS, Borisevich VG, Leonova GN.

Antibiot Khimioter. 2001;46(7):23-6. Russian.

PMID:
11697240
42.

[Experimental tick-borne encephalitis in golden hamsters treated with specific immunotherapy].

Leonova GN, Isachkova LM, Borisevich VG, Fisenko AIu.

Vopr Virusol. 2000 Jul-Aug;45(4):28-33. Russian.

PMID:
10971963
43.

[Apoptosis as a mechanism for the cytopathic action of tick-borne encephalitis virus].

Isaeva MP, Leonova GN, Kozhemiako VB, Borisevich VG, Maĭstrovskaia OS, Rasskazov VA.

Vopr Virusol. 1998 Jul-Aug;43(4):182-6. Russian.

PMID:
9791885
44.

[Antigenemia in people infected with tick-borne encephalitis virus].

Leonova GN, Maĭstrovskaia OS, Borisevich VB.

Vopr Virusol. 1996 Nov-Dec;41(6):260-3. Russian.

PMID:
8999682
45.

[Skeletal mineralization in cattle in 1960 and 1990 based on trephine biopsy data].

Borisevich VB, Mel'nikova NN, Kudriavchenko AV, Mel'nik OP.

Morfologiia. 1993 May-Jun;104(5-6):84-9. Russian.

PMID:
8012543
46.

[Radiologic and histologic study of trepanobioptates of the spongy bones in cattle in regions suffering as a result of the accident at the Chernobyl AES].

Borisevich VB, Kudriavchenko AV, Sen' IaG, Iatsyshin AI, Tkachenko GM, Borisevich BV.

Radiobiologiia. 1992 Sep-Oct;32(5):647-53. Russian. No abstract available.

PMID:
1448552
47.

[Pathogenesis of conjunctivitis in domestic animals].

Borisevich VB.

Veterinariia. 1979 Sep;(9):58-60. Russian. No abstract available.

PMID:
506042
48.

[Lacrimal glands of dogs and cattle in the light of histologic and histochemical findings].

Borisevich VB.

Arkh Anat Gistol Embriol. 1976 Sep;71(9):12-7. Russian.

PMID:
985105
49.

[State of the horns in cattle in the normal state and in deformations].

Borisevich VB.

Veterinariia. 1975 Jun;(6):98-100. Russian. No abstract available.

PMID:
174276
50.

[Working conditions and state of health of operators of railway roadbed equipment].

Gol'dman EI, Dorfman AA, Goncharov VD, Borisevich VF, Perekrest AI.

Gig Tr Prof Zabol. 1973 Oct;17(10):45-6. Russian. No abstract available.

PMID:
4791629

Supplemental Content

Loading ...
Support Center